ClinicalTrials.gg
Sign In

Nocturia clinical trials

The registry lists 134 studies for Nocturia across more than 10 countries. 22 are recruiting or about to start. 79 of them are mainly about Nocturia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.

Get an email when these change. Save the Nocturia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
89
Recruiting
17
Terminated
7
Status unknown
7
Not yet recruiting
5
Withdrawn
5

Phase

Phase 3
25
Phase 2
20
Phase 4
19
Phase 1
12
Early Phase 1
1

Where

United States
57
Belgium
13
Canada
12
Germany
10
United Kingdom
8
Korea, Republic of
8

Who runs them

Ferring Pharmaceuticals (19) · Vantia Ltd (10) · University Hospital, Ghent (9) · Serenity Pharmaceuticals, Inc. (6) · InnoCon Medical (4) · Atlanta VA Medical Center (3) · Seoul National University Hospital (3) · University of Pittsburgh (3)

What is being tested here

Drugs under test in Nocturia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Mirabegron234
Solifenacin145
Tolterodine112
Lemborexant101
Oxybutynin111
Onabotulinum toxin A101
Botulinum toxin type A101
Deamino Arginine Vasopressin01624
VA106483006
Fedovapagon014

Drug classes tested here Antimuscarinics 1 open

Coming up

1phase 3 study under way
14studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 17 Nocturia studies recruiting now, 13 (76%) set no upper age limit and 2 (12%) stop at 75 or younger. 0 (0%) take children under 18. 8 (47%) are for women only and 2 (12%) for men only; 5 (29%) take healthy volunteers.

Recruiting studies that take each age, of 17
AgeWomenMen
100 (0%)0 (0%)
187 (41%)5 (29%)
308 (47%)5 (29%)
4010 (59%)6 (35%)
5011 (65%)7 (41%)
6515 (88%)9 (53%)
7514 (82%)9 (53%)
8512 (71%)8 (47%)

Across all 134 studies, recruiting or not: 21% stop at 75 or younger and 16% at 65; 5% take children; 28% are for women only and 22% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Nocturia studies take

Of 34 interventional studies with no phase under Nocturia, half reached primary completion within 17 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase17 mo7–37 · 34 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Started recruiting1

Results posted1

Studies

Recruiting first, then most recently updated. Showing 50 of 134. Browse all 134 → or search them.